X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. ORCL

Go back to X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

X4 Pharmaceuticals (XFOR) Misses Q1 EPS by 44c

May 6, 2021 8:25 AM EDT

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q1 EPS of ($1.30), $0.44 worse than the analyst estimate of ($0.86).

We are excited by the strong progress we have achieved to date in 2021 in the development of mavorixafor across multiple rare disease indications, said Paula Ragan, Ph.D., President and Chief... More